UnitedHealth Group
Q1 2022 Earnings Call
Apr 14, 2022, 8:45 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Good morning, and welcome to the UnitedHealth Group first quarter 2022 earnings conference call. A question-and-answer session will follow UnitedHealth Group's prepared remarks. And as a reminder, this call is being recorded. Here are some important introductory information.
This call contains forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause the actual results to differ materially from the historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current periodic filings.
This call will also reference non-GAAP amounts, a recorrelation of the non-GAAP to the GAAP amounts available on the financial and earnings reports section of the company's Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning in our Form 8-K dated April 14, 2022, which will be accessed from the Investor Relations page of the company's website. I will now turn the conference over to chief executive officer of the UnitedHealth Group, Andrew Witty. Please go ahead.
Andrew Witty -- Chief Executive Officer
Thank you. Good morning, and thank you all for joining us today. Coming into this quarter, we set clear objectives for the year: To drive strong execution of our long-term strategy and deliver high-quality diversified growth; pursue excellence in every consumer experience and at every touch point; and apply technology to help all stakeholders to improve access, affordability, outcomes, and experiences. As our results show, we're delivering on these objectives.
I would like to start this morning's call by thanking my colleagues, the 350,000 people of Optum and UnitedHealthcare. Their dedicated work gives us the confidence today to increase our 2022 adjusted earnings per share outlook to a range of $21.20 to $21.70 per share. At our November investor conference, we described five key areas to drive our long-term 13% to 16% earnings-per-share growth rate. In the first area, value-based care delivery, OptumHealth continued its robust momentum into the first quarter, characterized by its integrated approach and high clinical quality.